The Regulatory Environment Surrounding Cannabis Medicines in the EU, the USA, and Australia
<b>Background/Objectives</b>: Recent evidence supporting the medicinal use of cannabis has brought significant regulatory changes regarding its legal status, cultivation, and use. Several countries have adopted regulatory strategies enabling access to cannabis-based medicinal products; h...
Saved in:
| Main Authors: | Claudia Jardim, M. Begoña Delgado-Charro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/5/635 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabis tolerance reduces symptom relief
by: Sarah S. Stith, et al.
Published: (2025-06-01) -
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
by: Isaac Cowley, et al.
Published: (2025-04-01) -
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
by: Dolly Andrea Caicedo, et al.
Published: (2025-03-01) -
Medical cannabis for the management of pain in chronic pancreatitis with recurrent exacerbations: a case report
by: Felice Antonio Spaccavento, et al.
Published: (2025-08-01) -
Compassionate use of medicinal Cannabis for pain treatment in children
with Klippel-Trenaunay Syndrome. Case report
by: Michelle dos Santos Severino Costa, et al.
Published: (2024-12-01)